Notice of Application to Register a Trade Name Product (Notice No. MPI 734)
Maree Zinzley, Manager Approvals Operations of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), that the following application has been made to register a trade name product under section 9(1) of the Act:
Trade Name: VANGUARD® CC 3 Intranasal
Reference: A011428
Active Ingredients and Concentrations:
Bordetella bronchiseptica, canine adenovirus type 2 and parainfluenza vaccine
Formulation Type: Aqueous solution or suspension (on reconstitution)
General Use Claim:
For vaccination of healthy dogs 8 weeks of age or older as an aid in preventing respiratory disease caused by canine adenovirus type 2 (CAV-2) virus, canine parainfluenza caused by canine parainfluenza (CPI) virus, and disease caused by Bordetella bronchiseptica.
Any person may make a written submission to the director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.
The following address is:
ACVM Group, Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.
The applicant’s address for service is:
Zoetis New Zealand Limited, Level 5, 8 Mahuhu Crescent, Auckland Central, Auckland 1010. Postal Address: PO Box 2094, Shortland Street, Auckland 1140.
Dated at Wellington this 28th day of March 2017.
MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).